GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...

The Trump administration is planning to pilot covering weight loss drugs. A longtime healthcare exec moves to a strategic advisory role at General Catalyst.

Medicare Advantage usage trends reveal slight declines in 2023, highlighting critical insights for policymakers amid rising ...

The Londonderry Township board of supervisors has postponed the decision on changing zoning rules to allow an AI data center ...

Legislative efforts and a Trump administration initiative could lead in the near future to Medicare beneficiary access to ...